BRIEF published on 07/07/2025 at 15:05, 11 months 1 day ago Applied DNA Sciences se conforme aux normes de cotation du Nasdaq Biotechnologie Sciences Appliquées De L'ADN Conformité Au Nasdaq Technologies De L'ADN LineaRx
BRIEF published on 07/07/2025 at 15:05, 11 months 1 day ago Applied DNA Sciences Complies with Nasdaq Listing Standards Biotechnology Nasdaq Compliance Applied DNA Sciences DNA Technologies LineaRx
PRESS RELEASE published on 07/07/2025 at 15:00, 11 months 1 day ago Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements Applied DNA Sciences regains compliance with Nasdaq listing rule requiring minimum bid price of $1.00 per share. Company's securities to remain listed on Nasdaq Capital Market Nasdaq Compliance Applied DNA Sciences Nasdaq Capital Market Minimum Bid Price PCR-based DNA Technologies
BRIEF published on 06/17/2025 at 22:15, 11 months 21 days ago Transition de direction chez Applied DNA : le Dr Hayward, PDG, prend sa retraite Biotechnologie Changement De Direction Valeur Actionnariale ADN Appliqué Judy Murrah
BRIEF published on 06/17/2025 at 22:15, 11 months 21 days ago Leadership Transition at Applied DNA as CEO Dr. Hayward Retires Biotechnology Shareholder Value Leadership Change Applied DNA Judy Murrah
PRESS RELEASE published on 06/17/2025 at 22:10, 11 months 21 days ago Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward Judy Murrah appointed Chairperson and CEO of Applied DNA Sciences, succeeding Dr. James A. Hayward. Experienced executive aims to lead company's innovative DNA technologies CEO Appointment Applied DNA Sciences DNA Technologies Judy Murrah Dr. James A. Hayward
BRIEF published on 05/15/2025 at 22:10, 1 year ago Applied DNA Sciences enregistre une croissance modeste de ses revenus au deuxième trimestre 2025 Croissance Des Revenus Restructuration Stratégique Résultats Financiers Du Deuxième Trimestre Tendances Biopharmaceutiques Technologie De L'ADN
BRIEF published on 05/15/2025 at 22:10, 1 year ago Applied DNA Sciences Sees Modest Revenue Growth in Q2 2025 Revenue Growth Strategic Restructuring Q2 Financial Results DNA Technology Biopharma Trends
PRESS RELEASE published on 05/15/2025 at 22:05, 1 year ago Applied DNA Reports Second Quarter Fiscal 2025 Financial Results Applied DNA Sciences, Inc. (NASDAQ:APDN) reports a 44% Y/Y increase in LineaRx segment revenues contributing to a 6% total revenue growth. Strategic priorities and financial highlights for Q2 2025 disclosed Financial Results Strategic Priorities Applied DNA Sciences LineaRx Segment Therapeutic DNA Production
BRIEF published on 05/14/2025 at 17:35, 1 year ago Applied DNA Sciences publiera ses résultats financiers du deuxième trimestre et organisera une mise à jour pour les investisseurs Sciences Appliquées De L'ADN Conférence Téléphonique Pour Les Investisseurs Priorités Stratégiques Rediffusion Du Webcast Résultats Financiers Du Deuxième Trimestre 2025
Published on 06/08/2026 at 22:15, 27 minutes ago Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders
Published on 06/08/2026 at 21:50, 52 minutes ago Electric Royalties Announces Interest Conversion Under Convertible Credit Facility
Published on 06/08/2026 at 21:05, 1 hour 37 minutes ago Aureum Exploration Closes Initial Public Offering and Announces Commencement of Trading on the Canadian Securities Exchange
Published on 06/08/2026 at 14:30, 8 hours 12 minutes ago As the Ebola Emergency Outbreak Grows Rapidly, NanoViricides Has Proposed a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment - with Superior Oral Administration and Escape Resistance Features Over Antibodies
Published on 06/08/2026 at 13:30, 9 hours 12 minutes ago Eskay Mining Corp. Announces a Non-Brokered Flow-Through Private Placement of up to $3.5 million
Published on 06/08/2026 at 19:40, 3 hours 2 minutes ago CoinShares Digital Securities Limited: RIS CSDS Individual - Additional Market Maker
Published on 06/08/2026 at 19:35, 3 hours 7 minutes ago CoinShares Digital Securities Limited: RIS CSDS Index - Additional Market Maker 8.6.2026
Published on 06/08/2026 at 19:27, 3 hours 14 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/08/2026 at 19:23, 3 hours 18 minutes ago Sirma Acquires Romanian IT Company DynamiXRM
Published on 06/08/2026 at 19:00, 3 hours 42 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 01 JUIN 2026 au 05 JUIN 2026
Published on 06/08/2026 at 17:48, 4 hours 54 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 1er et le 4 juin 2026
Published on 06/08/2026 at 17:48, 4 hours 54 minutes ago Reporting on share buyback transactions carried out between June 1 and June 4, 2026
Published on 06/08/2026 at 17:45, 4 hours 57 minutes ago Déclaration hebdomadaire de rachat d'actions
